Dupilumab treatment was associated with improvements in linear growth and a bone mineralization biomarker among children with severe atopic dermatitis, according to a post hoc analysis of a phase 3 randomized trial and open-label extension.
Dupilumab treatment was associated with improvements in linear growth and a bone mineralization biomarker among children with severe atopic dermatitis, according to a post hoc analysis of a phase 3 randomized trial and open-label extension.
Janus kinase inhibitors demonstrated efficacy across several inflammatory skin diseases, according to a systematic review and meta-analysis encompassing 15,427 patients.
Janus kinase inhibitors demonstrated efficacy across several inflammatory skin diseases, according to a systematic review and meta-analysis encompassing 15,427 patients.
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how...
01/01/2026
The Dermatologist
Where Dermatology NPs and PAs Learn, Lead, and Level Up.
The Derm NP/PA is dedicated to educating and informing advanced practice providers on clinical topics and practical issues to support the profession and improve the quality of patient care across the spectrum of dermatology.
The Derm NP/PA is designed for advanced practice providers who specialize in dermatology to further their education and increase their knowledge to achieve better patient outcomes. Explore cutting-edge research, innovative treatment options, and new therapeutic methods while remaining focused on the fundamental principles and terminology associated with dermatology. Engage year-round with The Derm NP/PA to access clinical insights, interactive features, research news updates, accredited continuing-education programs, and more.